암 환자의 우울증

키워드

참고문헌 (113)

1. Brenner H, "Long-term survival rates of cancer patients achieved by the end of the 20th century:a period analysis", 360, pp.1131~1135 (2002)
2. McDaniel JS, "Depression in patients with cancer. Diagnosis, biology, and treatment", 52, pp.89~99 (1995)
3. Hotopf M, "Depression in advanced disease: A systematic review. Part 1. Prevalence and case finding.", 16, pp.81~97 (2002)
4. Massie MJ, "Prevalence of depression in patients with cancer", 32, pp.57~71 (2004)
5. Harrison J, "Influence of age on psychological adjustment to cancer", 4, pp.33~38 (1995)
6. Schain WS, "Sexual problems of patients with cancer", pp.2066~2082 (1986), Lippincett
7. Bukberg J, "Depression in hospitalized cancer patients", 46, pp.199~212
8. Norton TR, "Prevalence and predictors of psychological distress among women with ovarian cancer", 22, pp.919~926 (2004)
9. Burgess C, "Depression and anxiety in women with early breast cancer:five year observational cohort study", 330, pp.702~ (2005)
10. Ha HK, "Anxiety and depression of the hospitalized cancer patients", 21, pp.665~674 (1982)
11. Oh BH, "The comparison of anxiety and depression between cancer patients and non-cancer medical patients", 25, pp.121~131 (1986)
12. Lee CY, "Levels of anxiety and depression of the hospitalized cancer patients", 29, pp.178~187 (1990)
13. Roth AJ, "Psychiatric issues in older cancer patients", 48, pp.185~197 (2003)
14. Raison CL, "Depression in cancer:new developments regarding diagnosis and treatment", 54, pp.283~294 (2003)
15. Capuron L, "Timing and specificity of the cognitive changes induced by interleukin-2 and interferon-alpha treatments in cancer patients", 63, pp.376~386 (2001)
16. Raison CL, "Cancer and depression: Prevalence, diagnosis, and treatment", 7, pp.34~41 (2000)
17. Shekelle RB, "Psychological depression and 17-year risk of death from cancer", 43, pp.117~125 (1981)
18. Persky VW, "Personality and risk of cancer:20-year follow up of the Western Electric Study", 49, pp.435~449 (1987)
19. Everson SA, "Hopelessness and risk of mortality and incidence of myocardial infarction and cancer", 58, pp.113~121 (1996)
20. Herrmann C, "Diagnostic groups and depressed mood as predictors of 22-month mortality in medical inpatients", 60 (1998)
21. Watson M, "Influence of psychological response on survival in breast cancer:A population-based cohort study", 354, pp.1331~1336 (1999)
22. Loberiza FR Jr, "Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases", 20, pp.2118~2126 (2002)
23. Stommel M, "Depression and functional status as predictors of death among cancer patients", 94, pp.2719~2727 (2002)
24. Hjerl K, "Depression as a prognostic factor for breast cancer mortality", 44, pp.24~30 (2003)
25. Prieto JM, "Role of depression as a predictor of mortality among cancer patients after stem-cell transplantation", 23, pp.6063~6071 (2005)
26. Costa P Jr, "Depression as a risk for cancer morbidity and mortality in a nationally representative sample JAMA 1989"
27. Tross S, "Psychological symptoms and disease-free and overall survival in women with stage II breast cancer", 88, pp.661~667 (1996)
28. Kaplan GA, "Depression and cancer mortality and morbidity:Prospective evidence from the Alameda County study", 11, pp.113~ (1998)
29. Teno JM, "Prediction of survival for older hospitalized patients", 48(5), pp.1624~ (2000)
30. Spiegel D, "Depression and cancer:mechanisms and disease progression", 54, pp.269~82 (2003)
31. Williams LS, "Depression and other mental health diagnoses increase mortality risk after ischemic stroke", 161, pp.1090~1095 (2004)
32. Kamphuis MH, "Depressive symptoms as risk factor of cardiovascular mortality in older European men: the Finland, Italy and Netherlands Elderly (FINE) study.", 13, pp.199~206 (2006)
33. Takeshita J, "Are depressive symptoms a risk factor for mortality in elderly Japanese American men", 159, pp.1127~1132 (2002)
34. Lerman C, "Younger women at increased risk for breast cancer:Perceived risk,psychological well-being,and surveillance behavior", 16, pp.171~176 (1994)
35. Antoni MH, "The influence of bio-behavioral factors on tumour biology:pathways and mechanisms", 6, pp.240~248 (2006)
36. Touitou Y, "Rhythm alteration in patients with metastatic breast cancer and poor prognostic factors", 121, pp.181~188 (1995)
37. Callevaert DM, "Hormone specific regulation of natural killer cells by cortisol", 285, pp.108~110 (1991)
38. Romero LM, "A possible mechanism by which stress accelerates growth of virally-derived tumors", 89 (1992)
39. Rowse GJ, "Endocrine mediation of psychological stressor effects on mouse mammary tumor growth", 65, pp.85~93 (1992)
40. Licinio J, "A molecular mechanism for stress-induced alterations in susceptibility to disease", 346, pp.104~106 (1995)
41. Felten SY, "Noradrenergic sympathetic innervation of the spleen -positive nerve terminals form synapiclike contacts on lymphocytes in the splenic white pulp", pp.37~48
42. Levy S, "Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer", 5, pp.348~353 (1987)
43. Levy SM, "Immnunological and psychosocial predictors of disease recurrence in patients with early-stage breast cancer", 17, pp.67~75 (1991)
44. Agarwal SK, "Glucocorticoid-induced type 1", type 2 cytokine alterations in humans:a model for stress-related immune dysfunction, 1998, pp.18, 1059~1068
45. Reiche EM, "Stress, depression, the immune system, and cancer", 5, pp.617~625 (2004)
46. McGrath CM, "Induction of endogenous mammary tumor virus expression during hormonal induction of mammary adenoacanthomas and carcinomas of BALB", c female mice, 1981, pp.67, ~
47. Cohen L, "DNA repair capacity in healthy medical students during and after exam stress", 23, pp.531~544 (2000)
48. Tomei LD, "Psychological stress and phorbol ester inhibition of radiation-induced apoptosis PBLs", 33, pp.5971~ (1990)
49. Yousaf U, "Suicides among Danish cancer patients 1971-1999", 92, pp.995~1000 (2005)
50. Hem E, "Suicide risk in cancer patients from 1960 to 1999", 15(22), pp.4209~4216 (2004)
51. Bjorkenstam C, "Are cancer patients at higher suicide risk than the general population", 33, pp.208~214 (2005)
52. Innos K, "Cancer incidence and cause-specific mortality in male and female physicians:a cohort study in Estonia", 30, pp.133~140 (2002)
53. Duffy SA, "Effect of smoking,alcohol,and depression on the quality of life of head and neck cancer patients", 24, pp.140~147 (2002)
54. Lekander M, "Social support and immune status during and after chemotherapy for breast cancer", 35, pp.3137~ (1996)
55. Fawzy FI, "Malignant melanoma:effects of a brief,structured psychiatric intervention on survival and recurrence at 10-year follow-up", 60, pp.100~103 (2003)
56. Goodwin PJ, "The effect of group psychosocial support on survival in metastatic breast cancer", 345, pp.1719~1726 (2001)
57. Coussens LM, "Inflammation and cancer", 420, pp.860~867 (2002)
58. Lieb J, "Antidepressants, eicosanoids and the prevention and treatment of cancer.A review", 65, pp.23~239 (2001)
59. Ballin A, "The antidepressant fluvoxamine increases natural killer cell counts in cancer patients", 33, pp.720~723 (1997)
60. Serafeim A, "Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells", 101, pp.3212~3219 (2003)
61. Xia Z, "Changes in the generation of reactive oxygen species and in mitochondrial membrane potential during apoptosis induced by the antidepressants imipramine and citalopram and the effects on these changes by Bcl-2 and Bcl-X", 57, pp.1199~1208 (1999)
62. Xu W, "Use of antidepressants and risk of colorectal cancer:a nested case-control study", 7, pp.301~308 (2006)
63. Perron L, "Antihypertensive drug use and the risk of prostate cancer(Canada)", 15, pp.353~341 (2004)
64. Algazi M, "Could treatments with β-blockers be associated with a reduction in cancer risk", 52, pp.53~65 (2004)
65. Newport DJ, "Assessment and treatment of depression in the cancer patient", 45, pp.215~237 (1998)
66. American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders" (1994), American Psychiatric Press
67. de Jong N, "Fatigue in patients with breast cancer receiving adjuvant chemotherapy:a review of the literature", 25, pp.283~297 (2002)
68. Endicott J, "A diagnostic interview:the schedule for affective disorders and schizophrenia", 35, pp.837~844 (1978)
69. Spitzer RL, "Research Diagnostic Criteria:Rationale and reliability", 35, pp.7072~ (1978)
70. Kathol RG, "Diagnosis of major depression in cancer patients according to four sets of criteria", 147, pp.1021~1024 (1990)
71. First MB, "Structured Clinical Interview for DSM-IV Axis I DisordersPatient Edition" (1995)
72. Plumb M, "Comparative studies of psychological function in patients with advanced cancer:2", 43, pp.243~254
73. Endicott J, "Measurement of depression in patients with cancer", 53, pp.2243~2248 (1984)
74. Rapp SR, "Substituting nonsomatic for somatic symptoms in the diagnosis of depression in elderly male medical patients", 146, pp.1197~1200 (1989)
75. Chochinov HM, "Prevalence of depression in the terminally ill:effects of diagnostic criteria and symptom threshold judgements", 151, pp.537~540 (1994)
76. Hamilton M, "A rating scale for depression", 23, pp.56~62 (1960)
77. Montgomery SA, "A new depression scale designed to be sensitive to change", 134 (1979)
78. Galinowski A, "Structural validity of MADRS during antidepressant treatment", 10, pp.157~161 (1995)
79. Beck AT, "An inventory for measuring depression", 4, pp.561~571 (1961)
80. Zung WWK, "A self-rating depression scale", 12, pp.6370~ (1965)
81. Radloff LS, "The CES-D scale:a self-report depression scale for research in the general population", 1, pp.385~401 (1977)
82. Zigmond AS, "The hospital anxiety and depression scale", 67, pp.361~370 (1983)
83. Yesavage JA, "Development and validation of a geriatric depression screening scale:a preliminary report", 17, pp.37~49 (1983)
84. Trask PC, "Assessment of depression in cancer patients", 32, pp.80~92 (2004)
85. Oh SM, "A study on the standardization of the Hospital Anxiety and Depression Scale for Koreans", 38, pp.289~296 (1999)
86. National Comprehensive Cancer Network, "Distress management clinical practice guidelines", 1, pp.344~374 (2003)
87. Akizuki N, "Development of an impact thermometer for use in combination with the distress thermometer as a brief screening tool for adjustment disorders and", or major depression in cancer patients, 2005, pp.29, 91~99
88. Jacobsen PB, "Screening for psychologic distress in ambulatory cancer patients", 103, pp.1494~1502 (2005)
89. McIntyre RS, "Improving outcomes in depression:a focus on somatic symptoms", 60, pp.279~282 (2006)
90. Newell SA, "Systematic review of psychological therapies for cancer patients:overview and recommendations for the future", 94, pp.558~584 (2002)
91. Antoni MH, "Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early stage breast cancer", 20, pp.20~32 (2001)
92. Classen C, "Supportive-expressive group therapy and distress in patients with metastatic breast cancer:a randomized clinical intervention trial.", 58, pp.494~501 (2001)
93. Tatrow K, "Cognitive behavioral therapy techniques for distress and pain in breast cancer patients:A Meta-Analysis", 29, pp.17~27 (2006)
94. Charturved S, "Antidepressant medications in cancer patients", 3, pp.57~60 (1994)
95. Andrews JM, "Contemporary management of depression", 97 (1994)
96. Koriech OM., "Fluoxetine treatment comprise the antiemetic efficacy of ondansetron in cancer patients", 7, pp.371~372 (1995)
97. Fisch MJ, "Fluoxetine versus placebo in advanced cancer outpatients:a double-blinded trial", 21, pp.1937~1943 (2003)
98. Morrow GR, "Differential effects of paroxetine on fatigue and depression:a randomized,double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program", 21, pp.4635~4641 (2003)
99. Kimmick GG, "Randomized, double-blind, placebo-controlled, crossover study of sertraline for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen", 12, pp.114~122 (2006)
100. Loprinzi CL, "Phase III evaluation of fluoxetine for treatment of hot flashes", 20, pp.1578~1583 (2002)
101. Zylicz Z, "Paroxetine in the treatment of severe non-dermatological pruritus:a randomized,controlled trial", 26, pp.1105~1112 (2003)
102. Steingart A, "Antidepressant medication use and breast cancer risk:a case-control study", 32, pp.961~966 (2003)
103. Tasmuth T, "Venlafaxine in neuropathic pain following treatment of breast cancer", 6, pp.17~24 (2002)
104. Loprinzi CL, "Venlafaxine in management of hot flashes in survivors of breast cancer:a randomized controlled trial", 356, pp.2059~2063 (2000)
105. Guclu S, "Mirtazapine use in resistant hyperemesis gravidarum:report of three cases and review of the literature", 272, pp.298~300 (2005)
106. Kim JM, "Mirtazapine for severe gastroparesis unresponsive to conventional prokinetic treatment." (2006), in press
107. Thompson DS, "Mirtazapine for the treatment of depression and nausea in breast and gynecological oncology", 41, pp.356~359 (2000)
108. Davis MP, "Management of symptoms associated with advanced cancer:olanzapine and mirtazapine. A World Health Organization project", 2, pp.365~376 (2002)
109. Kim SW, "A Single Low Dose of Mirtazapine Can Induce Restless Legs Syndrome:Report of Two Cases", 16, pp.169~173 (2005)
110. Meyers CA, "Methylphenidate therapy improves cognition,mood,and function of brain tumor patients", 16, pp.2522~2527 (1998)
111. Bruera E, "The Use of methylphenidate in patients with incident cancer pain receiving regular opiates", 50, pp.75~77 (1992)
112. Homsi J, "A phase II study of methylphenidate for depression in advanced cancer", 18, pp.403~407 (2001)
113. Bruera E, "Patient controlled methylphenidate for cancer-related fatigue:a preliminary report", 22, pp.737~ (2003)

관련 논문AI추천